---
$id: https://graph.org.ai/products/commodity/51282529
$type: Product
source: UNSPSC
code: "51282529"
title: "Cefazaflur sodium"
class: "51282500"
classTitle: "First generation cephalosporins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cefazaflur sodium

**UNSPSC Code**: 51282529
**Class**: [First generation cephalosporins](First generation cephalosporins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes the sodium form of a cephalosporin antibiotic with the molecular structure C13H13F3N6O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 97I0692RNT chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-7-((((trifluoromethyl)thio)acetyl)amino)-, (6r-trans)-, but more commonly known as cefazaflur, which bears US NIH Compound Identifier 40239. European Medicines Agency schedules Cefazaflur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07377MIG. The term CEFAZAFLUR is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule cefazaflur sodium under HS 29419000 and SITC 54139. As of Q4 2014, CEFAZAFLUR SODIUM remains US FDA's Preferred Term for this commodity. Cefazaflur sodium bears US NLM identifiers UMLS ID C2825417 and NCI Concept Code C81028. SMILES: CN1C(NNN1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CSC(F)(F)F)SC2)C(=O)[O-].[NA+].

